K. Fukuda et al., SPECIFIC CYP3A4 INHIBITORS IN GRAPEFRUIT JUICE - FUROCOUMARIN DIMERS AS COMPONENTS OF DRUG-INTERACTION, Pharmacogenetics, 7(5), 1997, pp. 391-396
Four components were isolated from grapefruit juice that inhibit human
CYP3A-mediated drag oxidation. The structures of these compounds were
identified as furocoumarin derivatives by absorption spectra, APCI-li
quid chromatography/tandem mass spectrometry and nuclear magnetic reso
nance after their purification by reversed-phase high performance liqu
id chromatography, They include two new furocoumarins, pyran-4-yl)-4-h
exenyl]oxy]-3,7-dimethyl-2-octenyl] oxy]-7H-furo[3,2-g][1]benzopyran-7
-one (GF-I-1) and -[[4-methyl-1-(1-methylethenyl)-6-(7-oxo-7H-furo[3 l
-2-octenyl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one (GF-I-4). These furo
coumarins are strong candidates for causative agents of grapefruit jui
ce-mediated drug interaction, because of an inhibition potential that
is equal to or stronger than the prototypical CYP3A4 inhibitor, ketoco
nazole, on liver microsomal testosterone 6 beta-hydroxylation.